Your browser doesn't support javascript.
loading
Association of an organ transplant-based approach with a dramatic reduction in postoperative complications following radical nephrectomy and tumor thrombectomy in renal cell carcinoma.
González, Javier; Gaynor, Jeffrey J; Martínez-Salamanca, Juan I; Capitanio, Umberto; Tilki, Derya; Carballido, Joaquín A; Chantada, Venancio; Daneshmand, Siamak; Evans, Christopher P; Gasch, Claudia; Gontero, Paolo; Haferkamp, Axel; Huang, William C; Espinós, Estefania Linares; Master, Viraj A; McKiernan, James M; Montorsi, Francesco; Pahernik, Sascha; Palou, Juan; Pruthi, Raj S; Rodriguez-Faba, Oscar; Russo, Paul; Scherr, Douglas S; Shariat, Shahrokh F; Spahn, Martin; Terrone, Carlo; Vera-Donoso, Cesar; Zigeuner, Richard; Hohenfellner, Markus; Libertino, John A; Ciancio, Gaetano.
Afiliação
  • González J; Department of Urolorgy, Hospital General Universitario Gregorio Marañón, Madrid, Spain. Electronic address: fcojavier.gonzalez@salud.madrid.org.
  • Gaynor JJ; The Lillian Jean Kaplan Renal Transplant Center and the Miami Transplant Institute, Department of Surgery, University of Miami Miller School of Medicine, Miami, FL, USA. Electronic address: jgaynor@med.miami.edu.
  • Martínez-Salamanca JI; Servicio de Urología, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain. Electronic address: jims09@me.com.
  • Capitanio U; Department of Urology, Hospital San Raffaele, University Vita-Salute, Milano, Italy. Electronic address: umbertocapitanio@gmail.com.
  • Tilki D; Department of Urology, University of California, Davis, School of Medicine, Sacramento, CA, USA. Electronic address: dtilki@me.com.
  • Carballido JA; Servicio de Urología, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain. Electronic address: carballidojoaquin@gmail.com.
  • Chantada V; Servicio de Urología, Complejo Hospitalario Universitario de A Coruña, A Coruña, Spain. Electronic address: vchantada@hotmail.com.
  • Daneshmand S; USC/Norris Comprehensive Cancer Center, Los Angeles, CA, USA. Electronic address: daneshma@med.usc.edu.
  • Evans CP; Department of Urology, University of California, Davis, School of Medicine, Sacramento, CA, USA. Electronic address: cpevans@ucdavis.edu.
  • Gasch C; Department of Urology, University of Heidelberg, Heidelberg, Germany. Electronic address: claudia.gasch@med.uni-heidelberg.de.
  • Gontero P; Department of Urology, A.O.U. San Giovanni Battista, University of Turin, Turin, Italy. Electronic address: paolo.gontero@unito.it.
  • Haferkamp A; Department of Urology and Pediatric Urology, Mainz University Medical Center, Mainz, Germany. Electronic address: axel.haferkamp@unimedizin-mainz.de.
  • Huang WC; Department of Urology, New York University Langone School of Medicine, New York, USA. Electronic address: william.huang@nyumc.org.
  • Espinós EL; Department of Urology, Hospital Universitario La Paz, Madrid, Spain. Electronic address: estefanialinares@gmail.com.
  • Master VA; Department of Urology, Emory University, Atlanta, GA, USA. Electronic address: vmaster@emory.edu.
  • McKiernan JM; Department of Urology, Columbia University College of Physicians and Surgeons, New York, USA. Electronic address: jmm23@cumc.columbia.edu.
  • Montorsi F; Department of Urology, Hospital San Raffaele, University Vita-Salute, Milano, Italy. Electronic address: montorsi.francesco@hsr.it.
  • Pahernik S; Department of Urology, Paracelsus University Hospital (PMU), Nürnberg, Germany. Electronic address: sascha.pahernik@klinikum-nuernberg.de.
  • Palou J; Department of Urology, Fundació Puigvert, Barcelona, Spain. Electronic address: jpalou@fundacio-puigvert.es.
  • Pruthi RS; Department of Urology, UNC at Chapel Hill, Chapel Hill, NC, USA. Electronic address: raj_pruthi@med.unc.edu.
  • Rodriguez-Faba O; Department of Urology, Fundació Puigvert, Barcelona, Spain. Electronic address: orodriguez@fundacio-puigvert.es.
  • Russo P; Department of Surgery, Urology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address: russop@mskcc.org.
  • Scherr DS; Department of Urology, Weill Cornell Medical Center, New York, USA. Electronic address: dss2001@med.cornell.edu.
  • Shariat SF; Department of Urology, Medical University of Vienna, Vienna General Hospital, Vienna, Austria. Electronic address: sfshariat@gmail.com.
  • Spahn M; Department of Urology, Center of Urology/Prostate Cancer Center Hirslanden, Zürich, Switzerland. Electronic address: martin.spahn@hirslanden.ch.
  • Terrone C; Division of Urology, Maggiore della Carita Hospital, University of Eastern Piedmont, Novara, Italy. Electronic address: carlo.terrone@med.uniupo.it.
  • Vera-Donoso C; Hospital Universitario y Politécnico La Fe, Valencia, Spain. Electronic address: cdveradonoso@gmail.com.
  • Zigeuner R; Department of Urology, Medical University of Graz, Graz, Austria. Electronic address: richard.zigeuner@medunigraz.at.
  • Hohenfellner M; Department of Urology, University of Heidelberg, Heidelberg, Germany. Electronic address: markus.hohenfellner@med.uni-heidelberg.de.
  • Libertino JA; Department of Urology, Emerson Hospital-MGH Cancer Center, Boston, MA, USA. Electronic address: john.libertino@outlook.com.
  • Ciancio G; The Lillian Jean Kaplan Renal Transplant Center and the Miami Transplant Institute, Department of Surgery, University of Miami Miller School of Medicine, Miami, FL, USA. Electronic address: gciancio@med.miami.edu.
Eur J Surg Oncol ; 45(10): 1983-1992, 2019 Oct.
Article em En | MEDLINE | ID: mdl-31155470
OBJECTIVES: Our aim was to determine whether using an organ transplant-based(TB) approach reduces postoperative complications(PCs) following radical nephrectomy(RN) and tumor thrombectomy(TT) in renal cell carcinoma(RCC) patients with level II-IV thrombi. METHODS: A total of 390(292 non-TB/98 TB) IRCC-VT Consortium patients who received no preoperative embolization/IVC filter were included. Stepwise linear/logistic regression analyses were performed to determine significant multivariable predictors of intraoperative estimated blood loss(IEBL), number blood transfusions received, and overall/major PC development within 30days following surgery. Propensity to receive the TB approach was controlled. RESULTS: The TB approach was clearly superior in limiting IEBL, blood transfusions, and PC development, even after controlling for other significant prognosticators/propensity score(P < .000001 in each case). Median IEBL for non-TB/TB approaches was 1000 cc/300 cc and 1500 cc/500 cc for tumor thrombus Level II-III patients, respectively, with no notable differences for Level IV patients(2000 cc each). In comparing PC outcomes between non-TB/TB patients with a non-Right-Atrium Cranial Limit, the observed percentage developing a: i) PC was 65.8%(133/202) vs. 4.3%(3/69) for ECOG Performance Status(ECOG-PS) 0-1, and 84.8%(28/33) vs. 25.0%(4/16) for ECOG-PS 2-4, and ii) major PC was 16.8%(34/202) vs. 1.4%(1/69) for ECOG-PS 0-1, and 27.3%(9/33) vs. 12.5%(2/16) for ECOG-PS 2-4. Major study limitation was the fact that all TB patients were treated by a single, experienced, high volume surgeon from one center (non-TB patients were treated by various surgeons at 13 other centers). CONCLUSIONS: Despite this major study limitation, the observed dramatic differences in PC outcomes suggest that the TB approach offers a major breakthrough in limiting operative morbidity in RCC patients receiving RN and TT.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Complicações Pós-Operatórias / Trombose / Transfusão de Sangue / Carcinoma de Células Renais / Trombectomia / Neoplasias Renais / Nefrectomia Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Complicações Pós-Operatórias / Trombose / Transfusão de Sangue / Carcinoma de Células Renais / Trombectomia / Neoplasias Renais / Nefrectomia Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article